Subjective cognitive decline predicts future dementia risk, study finds

FHS
July 8, 2024
3:12 am

A study in JAMA Psychiatry finds that subjective cognitive decline (SCD) significantly predicts the risk of mild cognitive impairment (MCI), Alzheimer’s disease (AD), and all-cause dementia in older adults.

BARDA awards Emergent 10-year, $704M contract for Ebola treatment

Emergent BioSolutions has landed a $704 million contract from BARDA. The manufacturer announced the BARDA award on Tuesday for a 10-year contract to develop and

August 2, 2023

Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused

October 31, 2023

The power of generative AI in healthcare: Unmasking 5 key factors beyond the hype

There’s no doubt about the biggest story in tech over the last year: the rapid rise of generative AI. Although the underlying technology that powers

January 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.